These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 21724997)

  • 41. Modulation of fibrin cofactor activity in plasminogen activation.
    Nesheim M; Walker J; Wang W; Boffa M; Horrevoets A; Bajzar L
    Ann N Y Acad Sci; 2001; 936():247-60. PubMed ID: 11460482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Regulatory mechanism of fibrinolysis system by thrombin activatable fibrinolysis inhibitor (TAFI)].
    Urano T
    Nihon Yakurigaku Zasshi; 2000 Nov; 116(5):298-303. PubMed ID: 11215380
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.
    Von dem Borne PA; Bajzar L; Meijers JC; Nesheim ME; Bouma BN
    J Clin Invest; 1997 May; 99(10):2323-7. PubMed ID: 9153272
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression.
    Beuscher HU; Rödel F; Forsberg A; Röllinghoff M
    Infect Immun; 1995 Apr; 63(4):1270-7. PubMed ID: 7890384
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA; Cox LM; Bouma BN
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis.
    Konieczynska M; Fil K; Bazanek M; Undas A
    Thromb Haemost; 2014 Apr; 111(4):685-93. PubMed ID: 24306139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Fibrin(ogen) drives repair after acetaminophen-induced liver injury via leukocyte α
    Kopec AK; Joshi N; Cline-Fedewa H; Wojcicki AV; Ray JL; Sullivan BP; Froehlich JE; Johnson BF; Flick MJ; Luyendyk JP
    J Hepatol; 2017 Apr; 66(4):787-797. PubMed ID: 27965156
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of fibrinolytic activity by measuring the lysis time of a tissue-factor-induced clot: a feasibility evaluation.
    Cellai AP; Lami D; Magi A; Liotta AA; Rogolino A; Antonucci E; Bandinelli B; Abbate R; Prisco D
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):337-44. PubMed ID: 19117964
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetics of activated thrombin-activatable fibrinolysis inhibitor (TAFIa)-catalyzed cleavage of C-terminal lysine residues of fibrin degradation products and removal of plasminogen-binding sites.
    Foley JH; Cook PF; Nesheim ME
    J Biol Chem; 2011 Jun; 286(22):19280-6. PubMed ID: 21467042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis.
    Noll A; Roggenkamp A; Heesemann J; Autenrieth IB
    Infect Immun; 1994 Jul; 62(7):2784-91. PubMed ID: 7911784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fibrinogen and Antifibrinolytic Proteins: Interactions and Future Therapeutics.
    Pechlivani N; Kearney KJ; Ajjan RA
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC; Middeldorp S; Tekelenburg W; van den Ende AE; Tans G; Prins MH; Rosing J; Büller HR; Bouma BN
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ambiguous role of interleukin-12 in Yersinia enterocolitica infection in susceptible and resistant mouse strains.
    Bohn E; Schmitt E; Bielfeldt C; Noll A; Schulte R; Autenrieth IB
    Infect Immun; 1998 May; 66(5):2213-20. PubMed ID: 9573110
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model.
    Nagashima M; Werner M; Wang M; Zhao L; Light DR; Pagila R; Morser J; Verhallen P
    Thromb Res; 2000 May; 98(4):333-42. PubMed ID: 10822080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intrahepatic fibrin(ogen) deposition drives liver regeneration after partial hepatectomy in mice and humans.
    Groeneveld D; Pereyra D; Veldhuis Z; Adelmeijer J; Ottens P; Kopec AK; Starlinger P; Lisman T; Luyendyk JP
    Blood; 2019 Mar; 133(11):1245-1256. PubMed ID: 30655274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleotide-binding oligomerization domain 2 (Nod2) is dispensable for the innate immune responses of macrophages against Yersinia enterocolitica.
    Jeong YJ; Kim CH; Song EJ; Kang MJ; Kim JC; Oh SM; Lee KB; Park JH
    J Microbiol; 2012 Jun; 50(3):489-95. PubMed ID: 22752913
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
    Heesemann J; Gaede K; Autenrieth IB
    APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Destabilization of YopE by the ubiquitin-proteasome pathway fine-tunes Yop delivery into host cells and facilitates systemic spread of Yersinia enterocolitica in host lymphoid tissue.
    Gaus K; Hentschke M; Czymmeck N; Novikova L; Trülzsch K; Valentin-Weigand P; Aepfelbacher M; Ruckdeschel K
    Infect Immun; 2011 Mar; 79(3):1166-75. PubMed ID: 21149597
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines.
    Dube PH; Handley SA; Lewis J; Miller VL
    Infect Immun; 2004 Jun; 72(6):3561-70. PubMed ID: 15155665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A direct oral anticoagulant edoxaban accelerated fibrinolysis via enhancement of plasmin generation in human plasma: dependent on thrombin-activatable fibrinolysis inhibitor.
    Morishima Y; Honda Y
    J Thromb Thrombolysis; 2019 Jul; 48(1):103-110. PubMed ID: 30972711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.